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Cell-Free Heme Exhibits Dose Dependent 
Lethality in a Murine Model of Sepsis
Sahil Mehta
Mentor: Kenneth Remy
Sepsis is a disease caused by invasive infection, which causes systemic inflammation and 
leads to greater than four million deaths worldwide. About 50% of critically ill children 
suffering from sepsis in the U.S. receive a blood transfusion during their stay in the 
ICU. Recent research has led to mounting evidence indicating that RBC transfusions 
in patients with sepsis are associated with altered immunity and worsened outcome. 
Transfusion in sepsis is associated with dysregulated immunity. During transfusion, 
some donor RBCs lyse, generating microparticles and free hemoglobin (Hb), which 
then release cell-free heme (CFH) into plasma. In septic adults, increased plasma Hb 
and depletion of the CFH scavenger, hemopexin (Hpx), are associated with increased 
mortality. Recent work (in animals) indicates that CFH in plasma may directly activate 
TLR4, the LPS receptor. As such, heme release in excess of plasma binding capacity has 
the potential to worsened inflammation and may influence survival.
We used a murine cecal ligation, puncture (CLP) model of sepsis, and mimicked 
RBC transfusion via exogenous, commercially obtained heme. After initial LD50 heme 
studies without sepsis, we conducted heme dose response preliminary studies in B6/C57 
strain mice and CLP (n=29) for 72 hours. After CLP (50% ligation-21G single puncture), 
each mouse was either injected via tail vein with PBS (control) or heme (10 ÂµM, 
50ÂµM, or 500ÂµM; n=9, 8, 10, 2 respectively). At 2 hours and 24 hours. post-CLP, 
heme measurement were obtained and each animal was re-dosed with PBS (control) or 
respective heme.
 All heme administered animals died by 61 hours (mean 40.4hÂ±12.5) in a dose 
dependent fashion, while controls had a 45% survival. Circulating heme levels were 
lowest among controls. Spleen, liver, and lung tissue samples showed an increase in 
apoptosis and tissue denudation as dosage of heme was increased.
 We demonstrate that three separate doses of heme given in a CLP model of 
murine sepsis has 100% lethality. Future studies will carefully investigate innate 
immune phenotype during sepsis evolution and evaluate the utilization and timing of 
administration of CFH and potentially scavengers (i.e., Hpx) to improve survival.
